Filing metadata

Accession number
0001169245-22-000063
Form type
Form 4
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
May 20, 2022
Reporting period
May 19, 2022
Description
Insider transaction

Explore SEC Filings Hub